Capsul News (@CapsulNews) header
Capsul News (@CapsulNews) profile picture

What moved in pharma and biotech, and why it matters to you. Free for a limited period. Sign up at https://teapaw.org/t.co/QdrdfsIlM0

Joined June 2026
Photo by Capsul News (@CapsulNews)Photo by Capsul News (@CapsulNews)Photo by Capsul News (@CapsulNews)Photo by Capsul News (@CapsulNews)Photo by Capsul News (@CapsulNews)Photo by Capsul News (@CapsulNews)Photo by Capsul News (@CapsulNews)Photo by Capsul News (@CapsulNews)Photo by Capsul News (@CapsulNews)Photo by Capsul News (@CapsulNews)
#WeekendRead Women experience medication side effects at roughly twice the rate of men. Guest contributor Jessica Federer asks a consequential question: what happens when healthcare's evidence base doesn't fully reflect the people it serves? The Long View. Read it here capsul.news/the-long-view-of…
1
11
#ICYMI Women account for roughly two-thirds of US GLP-1 users. Guest contributor Jessica Federer sees a broader lesson: some of healthcare’s most obvious opportunities may still be hiding in plain sight. The Long View. Read it here capsul.news/the-long-view-of…
1
12
A healthcare system built on incomplete data leaves lasting blind spots. Guest contributor Jessica Federer explores the implications of a striking fact: women weren't required in US studies until 1993. Read The Long View here capsul.news/the-long-view-of…
1
1
1
15
Guest contributor Jessica Federer, a globally recognized leader in health technologies and women’s health writes : AI changes how fast we analyze the data we have; sex-based differences change whether we have the right data in the first place. The Long View. Read it here... capsul.news/the-long-view-of…
1
29
Rasonque booked $197.6m in roughly five weeks to Sept. 30 after its Aug. 26 FDA approval, the best launch-quarter sales for an oncology drug ever. Revolution’s CEO is still tempering expectations. Why? Therapeutic Thursday. Read it here... capsul.news/therapeutic-thur…
1
1
1
31